ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 127 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $221,811 | -58.6% | 10,365 | +0.4% | 0.00% | -75.0% |
| Q3 2022 | $536,000 | -5.5% | 10,327 | -13.8% | 0.01% | -20.0% |
| Q2 2022 | $567,000 | -72.8% | 11,986 | -59.0% | 0.02% | -69.4% |
| Q1 2022 | $2,082,000 | +3.3% | 29,254 | +8.6% | 0.05% | +44.1% |
| Q4 2021 | $2,015,000 | +348.8% | 26,946 | +241.2% | 0.03% | +385.7% |
| Q3 2021 | $449,000 | -80.1% | 7,897 | -84.6% | 0.01% | -83.7% |
| Q2 2021 | $2,261,000 | +129.1% | 51,376 | +156.7% | 0.04% | +115.0% |
| Q1 2021 | $987,000 | -46.8% | 20,011 | -54.6% | 0.02% | -61.5% |
| Q4 2020 | $1,856,000 | +229.1% | 44,086 | +292.7% | 0.05% | +85.7% |
| Q2 2020 | $564,000 | +169.9% | 11,227 | +93.5% | 0.03% | +366.7% |
| Q2 2017 | $209,000 | -43.1% | 5,802 | -51.3% | 0.01% | -45.5% |
| Q1 2017 | $367,000 | -29.2% | 11,902 | -23.1% | 0.01% | -15.4% |
| Q4 2016 | $518,000 | +72.7% | 15,470 | +57.9% | 0.01% | +30.0% |
| Q1 2015 | $300,000 | -34.4% | 9,800 | +9.0% | 0.01% | -37.5% |
| Q4 2014 | $457,000 | -43.9% | 8,987 | -56.4% | 0.02% | -44.8% |
| Q3 2014 | $815,000 | – | 20,596 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |